Alpelisib Plus Olaparib for Advanced Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Clin. Cancer Res 2022 Feb 11;[EPub Ahead of Print], F Batalini, N Xiong, N Tayob, M Polak, J Eismann, LC Cantley, GI Shapiro, V Adalsteinsson, EP Winer, PA Konstantinopoulos, AD D'Andrea, EM Swisher, UA Matulonis, GM Wulf, EL MayerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.